BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25274248)

  • 1. Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry.
    Nummela P; Saarinen L; Thiel A; Järvinen P; Lehtonen R; Lepistö A; Järvinen H; Aaltonen LA; Hautaniemi S; Ristimäki A
    Int J Cancer; 2015 Mar; 136(5):E282-9. PubMed ID: 25274248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy.
    Gleeson EM; Feldman R; Mapow BL; Mackovick LT; Ward KM; Morano WF; Rubin RR; Bowne WB
    Am J Clin Oncol; 2018 Aug; 41(8):777-783. PubMed ID: 28263231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiles of high-grade and low-grade pseudomyxoma peritonei.
    Noguchi R; Yano H; Gohda Y; Suda R; Igari T; Ohta Y; Yamashita N; Yamaguchi K; Terakado Y; Ikenoue T; Furukawa Y
    Cancer Med; 2015 Dec; 4(12):1809-16. PubMed ID: 26475379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis.
    Shetty S; Thomas P; Ramanan B; Sharma P; Govindarajan V; Loggie B
    J Surg Res; 2013 Mar; 180(1):97-103. PubMed ID: 23199549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases.
    Yan F; Lin Y; Zhou Q; Chang H; Li Y
    Hum Pathol; 2020 Mar; 97():9-18. PubMed ID: 31926211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.
    Liu X; Mody K; de Abreu FB; Pipas JM; Peterson JD; Gallagher TL; Suriawinata AA; Ripple GH; Hourdequin KC; Smith KD; Barth RJ; Colacchio TA; Tsapakos MJ; Zaki BI; Gardner TB; Gordon SR; Amos CI; Wells WA; Tsongalis GJ
    Clin Chem; 2014 Jul; 60(7):1004-11. PubMed ID: 24821835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei.
    Nummela P; Leinonen H; Järvinen P; Thiel A; Järvinen H; Lepistö A; Ristimäki A
    Hum Pathol; 2016 Aug; 54():47-54. PubMed ID: 27038681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic analysis of appendiceal mucinous adenomas in identical twins, including one with pseudomyxoma peritonei.
    Shih IM; Yan H; Speyrer D; Shmookler BM; Sugarbaker PH; Ronnett BM
    Am J Surg Pathol; 2001 Aug; 25(8):1095-9. PubMed ID: 11474297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
    Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
    Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward the molecular dissection of peritoneal pseudomyxoma.
    Pietrantonio F; Perrone F; Mennitto A; Gleeson EM; Milione M; Tamborini E; Busico A; Settanni G; Berenato R; Caporale M; Morano F; Bossi I; Pellegrinelli A; Di Bartolomeo M; de Braud F; Baratti D; Bowne WB; Kusamura S; Deraco M
    Ann Oncol; 2016 Nov; 27(11):2097-2103. PubMed ID: 27502722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.
    Pietrantonio F; Berenato R; Maggi C; Caporale M; Milione M; Perrone F; Tamborini E; Baratti D; Kusamura S; Mariani L; Niger M; Mennitto A; Gloghini A; Bossi I; Settanni G; Busico A; Bagnoli PF; Di Bartolomeo M; Deraco M; de Braud F
    J Transl Med; 2016 May; 14(1):125. PubMed ID: 27154293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Mutation and Loss of Heterozygosity by Whole-Exome Sequencing Yields Insights into Pseudomyxoma Peritonei.
    Pengelly RJ; Rowaiye B; Pickard K; Moran B; Dayal S; Tapper W; Mirnezami A; Cecil T; Mohamed F; Carr N; Ennis S
    J Mol Diagn; 2018 Sep; 20(5):635-642. PubMed ID: 29936255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women.
    Szych C; Staebler A; Connolly DC; Wu R; Cho KR; Ronnett BM
    Am J Pathol; 1999 Jun; 154(6):1849-55. PubMed ID: 10362811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review.
    Lin YL; Ma R; Li Y
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2179-2188. PubMed ID: 32700107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-exome sequencing identified the genetic origin of a mucinous neoplasm in a mature cystic teratoma.
    Choi YJ; Lee SH; Kim MS; Jung SH; Hur SY; Chung YJ; Lee SH
    Pathology; 2016 Jun; 48(4):372-6. PubMed ID: 27114374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
    Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM
    Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC2 is a molecular marker for pseudomyxoma peritonei.
    O'Connell JT; Hacker CM; Barsky SH
    Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovary.
    Wang B; Yao J; Ma R; Liu D; Lu Y; Shi G; An L; Xia A; Chen F; Pang S; Zhai X; Liu G; Chen S; Xu M; Song L; Xu H
    Int J Cancer; 2021 Apr; 148(8):2036-2047. PubMed ID: 33403690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.